TF inhibitors (Merck & Co/Taisho/Tularik)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameTF inhibitors (Merck & Co/Taisho/Tularik)
Drug Alias Nameantiinflammatory transcription factors (Taisho/Tularik/Merck)antiinflammatory transcription factors (Tularik/Merck/Taisho)antiinflammatory transcription factors (Merck/Taisho/Tularik)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTranscription factors inhibitors
TargetsTranscription factors
Therapy Area/IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTularik Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck & Co IncTularik IncTaisho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAutoimmune Diseases +[4] 

Other Information

ATC CodeN/A
Related LinksN/A